オピオイド使用障害の世界市場 2019年版：種類別（ブプレノルフィン、メタドン、ナルトレキソン）、用途別（中程度痛み治療、重度痛み治療）

• 英文タイトル：Global Opioid Use Disorder Market 2019 by Company, Regions, Type and Application, Forecast to 2024

• レポートコード：C-GIR20G2922
• 出版社/出版日：GlobalInfoResearch / 2019年12月30日
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、105ページ
• 納品方法：Eメール
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥504,600 (USD3,480)	▷ お問い合わせ
Multi User	￥756,900 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,009,200 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

「オピオイド使用障害の世界市場2019年」は、グローバルにおけるオピオイド使用障害市場を展望するレポートです。オピオイド使用障害のグローバル市場概観、企業動向、企業別シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどを掲載しています。
・オピオイド使用障害の市場概観
・オピオイド使用障害の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等）
・オピオイド使用障害の企業別販売動向、市場シェア、市場集中度、競争動向
・オピオイド使用障害の世界市場規模
・オピオイド使用障害の北米市場分析（アメリカ、カナダ、メキシコ等）
・オピオイド使用障害のアメリカ市場規模推移
・オピオイド使用障害のカナダ市場規模推移
・オピオイド使用障害のメキシコ市場規模推移
・オピオイド使用障害のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）
・オピオイド使用障害のドイツ市場規模推移
・オピオイド使用障害のイギリス市場規模推移
・オピオイド使用障害のロシア市場規模推移
・オピオイド使用障害のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等）
・オピオイド使用障害の日本市場規模推移
・オピオイド使用障害の中国市場規模推移
・オピオイド使用障害の韓国市場規模推移
・オピオイド使用障害のインド市場規模推移
・オピオイド使用障害の東南アジア市場規模推移
・オピオイド使用障害の南米市場分析（ブラジル、アルゼンチン等）
・オピオイド使用障害の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等）
・オピオイド使用障害の種類別分析/販売量、売上、市場シェア（ブプレノルフィン、メタドン、ナルトレキソン）
・オピオイド使用障害の用途別分析/市場規模（中程度痛み治療、重度痛み治療）
・オピオイド使用障害の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測）
・オピオイド使用障害の販売チャネル・代理店・貿易業者・ディーラー分析

Scope of the Report:
The global Opioid Use Disorder market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Opioid Use Disorder.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Opioid Use Disorder market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Opioid Use Disorder market by product type and applications/end industries.

Market Segment by Companies, this report covers
Orexo
Camurus
Hikma Pharmaceuticals
Alkermes
Indivior
Titan Pharmaceuticals
MediciNova
Teva Pharmaceuticals
Omeros

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Buprenorphine
Methadone
Naltrexone

Market Segment by Applications, can be divided into
Moderate Pain Treatment
Severe Pain Treatment

レポート目次

Table of Contents

1 Opioid Use Disorder Market Overview
1.1 Product Overview and Scope of Opioid Use Disorder
1.2 Classification of Opioid Use Disorder by Types
1.2.1 Global Opioid Use Disorder Revenue Comparison by Types (2019-2024)
1.2.2 Global Opioid Use Disorder Revenue Market Share by Types in 2018
1.2.3 Buprenorphine
1.2.4 Methadone
1.2.5 Naltrexone
1.3 Global Opioid Use Disorder Market by Application
1.3.1 Global Opioid Use Disorder Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Moderate Pain Treatment
1.3.3 Severe Pain Treatment
1.4 Global Opioid Use Disorder Market by Regions
1.4.1 Global Opioid Use Disorder Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Opioid Use Disorder Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Opioid Use Disorder Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Opioid Use Disorder Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Opioid Use Disorder Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Opioid Use Disorder Status and Prospect (2014-2024)
1.5 Global Market Size of Opioid Use Disorder (2014-2024)
2 Company Profiles
2.1 Orexo
2.1.1 Business Overview
2.1.2 Opioid Use Disorder Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Orexo Opioid Use Disorder Revenue, Gross Margin and Market Share (2017-2018)
2.2 Camurus
2.2.1 Business Overview
2.2.2 Opioid Use Disorder Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Camurus Opioid Use Disorder Revenue, Gross Margin and Market Share (2017-2018)
2.3 Hikma Pharmaceuticals
2.3.1 Business Overview
2.3.2 Opioid Use Disorder Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Hikma Pharmaceuticals Opioid Use Disorder Revenue, Gross Margin and Market Share (2017-2018)
2.4 Alkermes
2.4.1 Business Overview
2.4.2 Opioid Use Disorder Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Alkermes Opioid Use Disorder Revenue, Gross Margin and Market Share (2017-2018)
2.5 Indivior
2.5.1 Business Overview
2.5.2 Opioid Use Disorder Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Indivior Opioid Use Disorder Revenue, Gross Margin and Market Share (2017-2018)
2.6 Titan Pharmaceuticals
2.6.1 Business Overview
2.6.2 Opioid Use Disorder Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Titan Pharmaceuticals Opioid Use Disorder Revenue, Gross Margin and Market Share (2017-2018)
2.7 MediciNova
2.7.1 Business Overview
2.7.2 Opioid Use Disorder Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 MediciNova Opioid Use Disorder Revenue, Gross Margin and Market Share (2017-2018)
2.8 Teva Pharmaceuticals
2.8.1 Business Overview
2.8.2 Opioid Use Disorder Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Teva Pharmaceuticals Opioid Use Disorder Revenue, Gross Margin and Market Share (2017-2018)
2.9 Omeros
2.9.1 Business Overview
2.9.2 Opioid Use Disorder Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Omeros Opioid Use Disorder Revenue, Gross Margin and Market Share (2017-2018)
3 Global Opioid Use Disorder Market Competition, by Players
3.1 Global Opioid Use Disorder Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Opioid Use Disorder Players Market Share
3.2.2 Top 10 Opioid Use Disorder Players Market Share
3.3 Market Competition Trend
4 Global Opioid Use Disorder Market Size by Regions
4.1 Global Opioid Use Disorder Revenue and Market Share by Regions
4.2 North America Opioid Use Disorder Revenue and Growth Rate (2014-2019)
4.3 Europe Opioid Use Disorder Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Opioid Use Disorder Revenue and Growth Rate (2014-2019)
4.5 South America Opioid Use Disorder Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Opioid Use Disorder Revenue and Growth Rate (2014-2019)
5 North America Opioid Use Disorder Revenue by Countries
5.1 North America Opioid Use Disorder Revenue by Countries (2014-2019)
5.2 USA Opioid Use Disorder Revenue and Growth Rate (2014-2019)
5.3 Canada Opioid Use Disorder Revenue and Growth Rate (2014-2019)
5.4 Mexico Opioid Use Disorder Revenue and Growth Rate (2014-2019)
6 Europe Opioid Use Disorder Revenue by Countries
6.1 Europe Opioid Use Disorder Revenue by Countries (2014-2019)
6.2 Germany Opioid Use Disorder Revenue and Growth Rate (2014-2019)
6.3 UK Opioid Use Disorder Revenue and Growth Rate (2014-2019)
6.4 France Opioid Use Disorder Revenue and Growth Rate (2014-2019)
6.5 Russia Opioid Use Disorder Revenue and Growth Rate (2014-2019)
6.6 Italy Opioid Use Disorder Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Opioid Use Disorder Revenue by Countries
7.1 Asia-Pacific Opioid Use Disorder Revenue by Countries (2014-2019)
7.2 China Opioid Use Disorder Revenue and Growth Rate (2014-2019)
7.3 Japan Opioid Use Disorder Revenue and Growth Rate (2014-2019)
7.4 Korea Opioid Use Disorder Revenue and Growth Rate (2014-2019)
7.5 India Opioid Use Disorder Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Opioid Use Disorder Revenue and Growth Rate (2014-2019)
8 South America Opioid Use Disorder Revenue by Countries
8.1 South America Opioid Use Disorder Revenue by Countries (2014-2019)
8.2 Brazil Opioid Use Disorder Revenue and Growth Rate (2014-2019)
8.3 Argentina Opioid Use Disorder Revenue and Growth Rate (2014-2019)
8.4 Colombia Opioid Use Disorder Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Opioid Use Disorder by Countries
9.1 Middle East and Africa Opioid Use Disorder Revenue by Countries (2014-2019)
9.2 Saudi Arabia Opioid Use Disorder Revenue and Growth Rate (2014-2019)
9.3 UAE Opioid Use Disorder Revenue and Growth Rate (2014-2019)
9.4 Egypt Opioid Use Disorder Revenue and Growth Rate (2014-2019)
9.5 Nigeria Opioid Use Disorder Revenue and Growth Rate (2014-2019)
9.6 South Africa Opioid Use Disorder Revenue and Growth Rate (2014-2019)
10 Global Opioid Use Disorder Market Segment by Type
10.1 Global Opioid Use Disorder Revenue and Market Share by Type (2014-2019)
10.2 Global Opioid Use Disorder Market Forecast by Type (2019-2024)
10.3 Buprenorphine Revenue Growth Rate (2014-2024)
10.4 Methadone Revenue Growth Rate (2014-2024)
10.5 Naltrexone Revenue Growth Rate (2014-2024)
11 Global Opioid Use Disorder Market Segment by Application
11.1 Global Opioid Use Disorder Revenue Market Share by Application (2014-2019)
11.2 Opioid Use Disorder Market Forecast by Application (2019-2024)
11.3 Moderate Pain Treatment Revenue Growth (2014-2019)
11.4 Severe Pain Treatment Revenue Growth (2014-2019)
12 Global Opioid Use Disorder Market Size Forecast (2019-2024)
12.1 Global Opioid Use Disorder Market Size Forecast (2019-2024)
12.2 Global Opioid Use Disorder Market Forecast by Regions (2019-2024)
12.3 North America Opioid Use Disorder Revenue Market Forecast (2019-2024)
12.4 Europe Opioid Use Disorder Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Opioid Use Disorder Revenue Market Forecast (2019-2024)
12.6 South America Opioid Use Disorder Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Opioid Use Disorder Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Opioid Use Disorder Picture
Table Product Specifications of Opioid Use Disorder
Table Global Opioid Use Disorder and Revenue (Million USD) Market Split by Product Type
Figure Global Opioid Use Disorder Revenue Market Share by Types in 2018
Figure Buprenorphine Picture
Figure Methadone Picture
Figure Naltrexone Picture
Table Global Opioid Use Disorder Revenue (Million USD) by Application (2014-2024)
Figure Opioid Use Disorder Revenue Market Share by Applications in 2018
Figure Moderate Pain Treatment Picture
Figure Severe Pain Treatment Picture
Table Global Market Opioid Use Disorder Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Opioid Use Disorder Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Opioid Use Disorder Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Opioid Use Disorder Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Opioid Use Disorder Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Opioid Use Disorder Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Opioid Use Disorder Revenue (Million USD) and Growth Rate (2014-2024)
Table Orexo Basic Information, Manufacturing Base and Competitors
Table Orexo Opioid Use Disorder Type and Applications
Table Orexo Opioid Use Disorder Revenue, Gross Margin and Market Share (2017-2018)
Table Camurus Basic Information, Manufacturing Base and Competitors
Table Camurus Opioid Use Disorder Type and Applications
Table Camurus Opioid Use Disorder Revenue, Gross Margin and Market Share (2017-2018)
Table Hikma Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Hikma Pharmaceuticals Opioid Use Disorder Type and Applications
Table Hikma Pharmaceuticals Opioid Use Disorder Revenue, Gross Margin and Market Share (2017-2018)
Table Alkermes Basic Information, Manufacturing Base and Competitors
Table Alkermes Opioid Use Disorder Type and Applications
Table Alkermes Opioid Use Disorder Revenue, Gross Margin and Market Share (2017-2018)
Table Indivior Basic Information, Manufacturing Base and Competitors
Table Indivior Opioid Use Disorder Type and Applications
Table Indivior Opioid Use Disorder Revenue, Gross Margin and Market Share (2017-2018)
Table Titan Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Titan Pharmaceuticals Opioid Use Disorder Type and Applications
Table Titan Pharmaceuticals Opioid Use Disorder Revenue, Gross Margin and Market Share (2017-2018)
Table MediciNova Basic Information, Manufacturing Base and Competitors
Table MediciNova Opioid Use Disorder Type and Applications
Table MediciNova Opioid Use Disorder Revenue, Gross Margin and Market Share (2017-2018)
Table Teva Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Teva Pharmaceuticals Opioid Use Disorder Type and Applications
Table Teva Pharmaceuticals Opioid Use Disorder Revenue, Gross Margin and Market Share (2017-2018)
Table Omeros Basic Information, Manufacturing Base and Competitors
Table Omeros Opioid Use Disorder Type and Applications
Table Omeros Opioid Use Disorder Revenue, Gross Margin and Market Share (2017-2018)
Table Global Opioid Use Disorder Revenue (Million USD) by Players (2014-2019)
Table Global Opioid Use Disorder Revenue Share by Players (2014-2019)
Figure Global Opioid Use Disorder Revenue Share by Players in 2017
Figure Global Opioid Use Disorder Revenue Share by Players in 2018
Figure Global Top 5 Players Opioid Use Disorder Revenue Market Share in 2018
Figure Global Top 10 Players Opioid Use Disorder Revenue Market Share in 2018
Figure Global Opioid Use Disorder Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Opioid Use Disorder Revenue (Million USD) by Regions (2014-2019)
Table Global Opioid Use Disorder Revenue Market Share by Regions (2014-2019)
Figure Global Opioid Use Disorder Revenue Market Share by Regions (2014-2019)
Figure Global Opioid Use Disorder Revenue Market Share by Regions in 2018
Figure North America Opioid Use Disorder Revenue and Growth Rate (2014-2019)
Figure Europe Opioid Use Disorder Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Opioid Use Disorder Revenue and Growth Rate (2014-2019)
Figure South America Opioid Use Disorder Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Opioid Use Disorder Revenue and Growth Rate (2014-2019)
Table North America Opioid Use Disorder Revenue by Countries (2014-2019)
Table North America Opioid Use Disorder Revenue Market Share by Countries (2014-2019)
Figure North America Opioid Use Disorder Revenue Market Share by Countries (2014-2019)
Figure North America Opioid Use Disorder Revenue Market Share by Countries in 2018
Figure USA Opioid Use Disorder Revenue and Growth Rate (2014-2019)
Figure Canada Opioid Use Disorder Revenue and Growth Rate (2014-2019)
Figure Mexico Opioid Use Disorder Revenue and Growth Rate (2014-2019)
Table Europe Opioid Use Disorder Revenue (Million USD) by Countries (2014-2019)
Figure Europe Opioid Use Disorder Revenue Market Share by Countries (2014-2019)
Figure Europe Opioid Use Disorder Revenue Market Share by Countries in 2018
Figure Germany Opioid Use Disorder Revenue and Growth Rate (2014-2019)
Figure UK Opioid Use Disorder Revenue and Growth Rate (2014-2019)
Figure France Opioid Use Disorder Revenue and Growth Rate (2014-2019)
Figure Russia Opioid Use Disorder Revenue and Growth Rate (2014-2019)
Figure Italy Opioid Use Disorder Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Opioid Use Disorder Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Opioid Use Disorder Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Opioid Use Disorder Revenue Market Share by Countries in 2018
Figure China Opioid Use Disorder Revenue and Growth Rate (2014-2019)
Figure Japan Opioid Use Disorder Revenue and Growth Rate (2014-2019)
Figure Korea Opioid Use Disorder Revenue and Growth Rate (2014-2019)
Figure India Opioid Use Disorder Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Opioid Use Disorder Revenue and Growth Rate (2014-2019)
Table South America Opioid Use Disorder Revenue by Countries (2014-2019)
Table South America Opioid Use Disorder Revenue Market Share by Countries (2014-2019)
Figure South America Opioid Use Disorder Revenue Market Share by Countries (2014-2019)
Figure South America Opioid Use Disorder Revenue Market Share by Countries in 2018
Figure Brazil Opioid Use Disorder Revenue and Growth Rate (2014-2019)
Figure Argentina Opioid Use Disorder Revenue and Growth Rate (2014-2019)
Figure Colombia Opioid Use Disorder Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Opioid Use Disorder Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Opioid Use Disorder Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Opioid Use Disorder Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Opioid Use Disorder Revenue Market Share by Countries in 2018
Figure Saudi Arabia Opioid Use Disorder Revenue and Growth Rate (2014-2019)
Figure UAE Opioid Use Disorder Revenue and Growth Rate (2014-2019)
Figure Egypt Opioid Use Disorder Revenue and Growth Rate (2014-2019)
Figure Nigeria Opioid Use Disorder Revenue and Growth Rate (2014-2019)
Figure South Africa Opioid Use Disorder Revenue and Growth Rate (2014-2019)
Table Global Opioid Use Disorder Revenue (Million USD) by Type (2014-2019)
Table Global Opioid Use Disorder Revenue Share by Type (2014-2019)
Figure Global Opioid Use Disorder Revenue Share by Type (2014-2019)
Figure Global Opioid Use Disorder Revenue Share by Type in 2018
Table Global Opioid Use Disorder Revenue Forecast by Type (2019-2024)
Figure Global Opioid Use Disorder Market Share Forecast by Type (2019-2024)
Figure Global Buprenorphine Revenue Growth Rate (2014-2019)
Figure Global Methadone Revenue Growth Rate (2014-2019)
Figure Global Naltrexone Revenue Growth Rate (2014-2019)
Table Global Opioid Use Disorder Revenue by Application (2014-2019)
Table Global Opioid Use Disorder Revenue Share by Application (2014-2019)
Figure Global Opioid Use Disorder Revenue Share by Application (2014-2019)
Figure Global Opioid Use Disorder Revenue Share by Application in 2018
Table Global Opioid Use Disorder Revenue Forecast by Application (2019-2024)
Figure Global Opioid Use Disorder Market Share Forecast by Application (2019-2024)
Figure Global Moderate Pain Treatment Revenue Growth Rate (2014-2019)
Figure Global Severe Pain Treatment Revenue Growth Rate (2014-2019)
Figure Global Opioid Use Disorder Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Opioid Use Disorder Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Opioid Use Disorder Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Opioid Use Disorder Revenue Market Forecast (2019-2024)
Figure Europe Opioid Use Disorder Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Opioid Use Disorder Revenue Market Forecast (2019-2024)
Figure South America Opioid Use Disorder Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Opioid Use Disorder Revenue Market Forecast (2019-2024)

Global Premenstrual Dysphoric Disorder (PMDD) Market 2019 by Company, Regions, Type and Application, Forecast to 2024
C-GIR20G2962 2019年12月30日 103Pages
「月経前不快気分障害（PMDD）の世界市場2019年」は、グローバルにおける月経前不快気分障害（PMDD）市場を展望するレポートです。月経前不快気分障害（PMDD）のグローバル市場概観、企業動向、企業別シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジ...

世界の甲状腺障害市場予測（～2024年）：企業別、地域別、種類・用途別

Global Thyroid Disorder Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR09F3573 2019年10月11日 101Pages
本調査レポートは、甲状腺障害の世界市場について調べ、まとめました。種類別セグメントは、甲状腺機能低下症、甲状腺機能亢進症等、用途別セグメントは、病院、診療所、その他等に区分しました。甲状腺障害の世界市場概観、企業動向、企業別甲状腺障害シェア、市場規模推移、市場規模予測（2019年-2024年）、主要...

双極性障害治療薬の世界市場 2019年版：種類別（オランザピン（ジプレキサ）、クエチアピン（セロクエル）、リスペリドン（リスパーダル）、アリプラゾール（アビリファイ）、ジプラシドン（ジオドン）、クロザピン（クロザリル））、用途別（ルマテペロン、中枢神経系（CNS）障害）

Global Bipolar Disorder Therapeutics Drugs Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
C-GIR20G0257 2019年12月30日 121Pages
「双極性障害治療薬の世界市場2019年」は、グローバルにおける双極性障害治療薬市場を展望するレポートです。双極性障害治療薬のグローバル市場概観、メーカー動向、メーカー別シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、ア...

世界の筋骨格障害幹細胞療法市場予測（～2024年）

Global Musculoskeletal Disorder Stem Cell Therapy Market 2019 by Manufacturers, Countries, Type and Application, Forecast to 2024
B-GIR09D2355 2019年9月11日 107Pages
本調査レポートは、筋骨格障害幹細胞療法の世界市場について調べ、まとめました。種類別セグメントは、同種、自己等、用途別セグメントは、筋疾患、骨格疾患等に区分しました。筋骨格障害幹細胞療法の世界市場概観、メーカー動向、メーカー別筋骨格障害幹細胞療法シェア、市場規模推移、市場規模予測（2019年-2024...

世界の色素沈着低下障害治療市場予測（～2024年）：企業別、地域別、種類・用途別

Global Hypopigmentation Disorder Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR09F3115 2019年9月16日 115Pages
本調査レポートは、色素沈着低下障害治療の世界市場について調べ、まとめました。種類別セグメントは、局所薬、レーザー、化学ピール、マイクロダーマブレーション、その他等、用途別セグメントは、病院、美容クリニック＆皮膚科センター、その他等に区分しました。色素沈着低下障害治療の世界市場概観、企業動向、企業別色...

世界の睡眠障害治療市場予測（～2024年）：企業別、地域別、種類・用途別

Global Sleep Disorder Therapies Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR09F3509 2019年9月12日 119Pages
本調査レポートは、睡眠障害治療の世界市場について調べ、まとめました。種類別セグメントは、不眠症、過度の睡眠、睡眠障害等、用途別セグメントは、病院薬局、オンライン薬局、小売薬局等に区分しました。睡眠障害治療の世界市場概観、企業動向、企業別睡眠障害治療シェア、市場規模推移、市場規模予測（2019年-20...

世界の季節性情動障害光療法市場予測（～2024年）

Global Seasonal Affective Disorder Light Therapy Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR09D4277 2019年9月18日 122Pages
本調査レポートは、季節性情動障害光療法の世界市場について調べ、まとめました。種類別セグメントは、光療法ランプ、光療法目覚まし時計等、用途別セグメントは、病院、診療所、医学研究センター、その他等に区分しました。季節性情動障害光療法の世界市場概観、企業動向、企業別季節性情動障害光療法シェア、市場規模推移...

世界の代謝障害治療薬市場予測（～2024年）

Global Metabolic Disorder Therapeutics Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR09D4128 2019年9月18日 138Pages
本調査レポートは、代謝障害治療薬の世界市場について調べ、まとめました。種類別セグメントは、リソソーム蓄積症、糖尿病、肥満、遺伝性代謝障害、高コレステロール血症等、用途別セグメントは、経口、非経口、その他等に区分しました。代謝障害治療薬の世界市場概観、企業動向、企業別代謝障害治療薬シェア、市場規模推移...

世界の季節性情動障害治療薬市場予測（～2024年）：企業別、地域別、種類・用途別

Global Seasonal Affective Disorder Therapeutics Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR09F3491 2019年9月10日 119Pages
本調査レポートは、季節性情動障害治療薬の世界市場について調べ、まとめました。種類別セグメントは、光療法（光線療法）、薬物療法、その他等、用途別セグメントは、病院、診療所、その他等に区分しました。季節性情動障害治療薬の世界市場概観、企業動向、企業別季節性情動障害治療薬シェア、市場規模推移、市場規模予測...

オピオイド麻酔薬市場：世界及び中国市場分析・予測（～2024年）

Opioid Anesthetics Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
C9OT4752 2019年10月8日 144Pages
「オピオイド麻酔薬市場：世界及び中国市場分析・予測（～2024年）」は、世界及び中国におけるオピオイド麻酔薬市場について調査・分析したレポートで、オピオイド麻酔薬の世界市場動向、市場規模、主要企業情報などが含まれています。オピオイド麻酔薬のタイプ別には、経口、注射に分けて分析し、地域別には、アメリカ...

オピオイド麻酔薬市場：世界及び中国市場分析・予測（～2024年） Opioid Anesthetics Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Opioid Anesthetics industry with a focus on the Chinese market. The report provides key statistics on the market status of the Opioid Anesthetics manufacturers…
世界の甲状腺障害市場予測（～2024年）：企業別、地域別、種類・用途別 Scope of the Report: The global Thyroid Disorder market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fas…
非オピオイド鎮痛パッチ市場：世界及び中国市場分析・予測（～2024年） Non-opioid Analgesic Patch Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Non-opioid Analgesic Patch industry with a focus on the Chinese market. The report provides key statistics on the market status of the Non-opioid Analg…
オピオイド誘発性便秘治療薬市場：世界及び中国市場分析・予測（～2024年） Opioid Induced Constipation Drugs Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Opioid Induced Constipation Drugs industry with a focus on the Chinese market. The report provides key statistics on the market status of the Op…
月経前不快気分障害（PMDD）の世界市場 2019年版：種類別（テーブル製品、インジェクト製品、その他）、用途別（病院、クリニック、その他） Scope of the Report: The global Premenstrual Dysphoric Disorder (PMDD) market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especia…